Congressionally Directed Medical Research Programs -- Kidney Cancer Research Program -- Early-Career Investigator Award

Funding Agency:
Department of Defense

The KCRP Academy of Kidney Cancer Investigators Awards support a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty emerging as potential leaders of kidney cancer research. The overarching goal of the Academy of Kidney Cancer Investigators (AKCI) is to develop successful, highly productive kidney cancer researchers in a collaborative research and career development environment.

The AKCI is a virtual career development and research training platform that consists of EarlyCareer Investigator (ECI)/Designated Mentor pairs from different institutions, and an Academy Dean. The KCRP AKCIECIA is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, mentors, Dean) as well as with the kidney cancer advocacy community.

The Academy Dean, selected in FY19, serves as a resource for the ECIs and mentors, assessing the progress of the ECIs, and facilitating communication and collaboration among all of the ECIs and mentors, as well as with research and advocacy communities. In addition to fostering ECI scientific development, the AKCI, through its leadership by the Academy Dean, provides professional and leadership development of the ECIs to include skills and competencies needed to fund and manage a productive laboratory or research team.

This FY21 program announcement is soliciting ECIs and Designated Mentors to join the newly established Academy. This award mechanism enables the ECI (the investigator named as the Principal Investigator [PI] on the application) to pursue a kidney cancer project that may be basic, translational, and/or clinical research. The Designated Mentor is not required to be at the same institution as the ECI.


  • Pre-Application Submission Deadline: Sep. 14, 2021
  • Application Submission Deadline: Oct. 5, 2020

Agency Website

Areas of Interest

The KCRP’s vision is to eliminate kidney cancer through collaboration and discovery. The mission of the FY21 KCRP is to promote rigorous, innovative, high-impact research in kidney cancer for the benefit of Service Members, Veterans, and the American public. Within this context, the KCRP is interested in supporting research and clinical care that addresses the KCRP Overarching Strategic Goals to: (1) increase understanding of the biology of kidney cancer; (2) develop novel therapeutic strategies for the treatment of kidney cancer; (3) improve patient care for kidney cancer; and (4) grow the field and increase collaboration in the area of kidney cancer.

Eligibility Requirements

Each investigator may be named on only one KCRP AKCIECIA application as a PI.

Early-Career Investigator ○ Must be less than 3 years from their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent as of the full application submission deadline. – A Statement of Eligibility is required with the submission of the full application. ○ Individuals in a postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent, at the time of full application submission deadline are not eligible. ○ May be a research- or physician-scientist. ○ Must not have a concurrent career development-like award at the time of this award. ○ Must commit no less than 25% effort to this award for the first 2 years.

Designated Mentor ○ Must be an independent, established kidney cancer researcher. ○ Must have kidney cancer research funding (past and present). ○ Must have a record of kidney cancer publications in peer-reviewed journals. ○ May be at the same institution as the ECI. ○ If not at the same institution, another Mentor (“Other Mentor,” see below) at the ECI’s institution must also be included in the application submission. ○ Must demonstrate a commitment (at least 5% effort for mentoring and participating in Academy activities – offsite meetings and webinars) to develop and sustain the ECI’s independent career in kidney cancer research.



Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY21 AKCIECIA will not exceed $725,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type



Junior Faculty


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 14, 2021